Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Kavea Panneerselvam"'
Endoscopic vacuum therapy for treatment of spontaneous and iatrogenic upper gastrointestinal defects
Autor:
Kavea Panneerselvam, Jake S. Jacob, Ronald E. Samuel, Andy Tau, Gyanprakash A. Ketwaroo, Wasif M. Abidi, Robert J. Sealock
Publikováno v:
Clinical Endoscopy, Vol 56, Iss 6, Pp 754-760 (2023)
Background/Aims Endoscopic vacuum therapy (EVT) can heal a variety of defects within the gastrointestinal (GI) tract via applying negative pressure, which reduces the defect size, aspirates the infected fluid, and promotes granulation tissue. Here we
Externí odkaz:
https://doaj.org/article/ce51eb8298c54042a0af92b87b9bec17
Autor:
Austin R, Thomas, Mostafa, Eyada, Miho, Kono, Krishnavathana, Varatharajalu, Yang, Lu, Guofan, Xu, Kavea, Panneerselvam, Malek, Shatila, Mehmet, Altan, Jennifer, Wang, John A, Thompson, Hao Chi, Zhang, Muhammad Ali, Khan, Gottumukkala S, Raju, Anusha S, Thomas, Yinghong, Wang
Publikováno v:
Journal of Cancer Research and Clinical Oncology.
Immune checkpoint inhibitors (ICIs) are efficacious for treating various malignancies. In addition to immune-related adverse events (irAEs), growing evidence suggests that ICIs might also be associated with diverticulitis. We aim to assess the clinic
Autor:
Dongfeng Tan, John A. Thompson, Mehmet Altan, Kavea Panneerselvam, Hao Chi Zhang, Yinghong Wang, Anusha Shirwaikar Thomas, Petros Grivas, Rajan Amin, David Richards, Phillip Lum, Dongguang Wei
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:896-904
Background: Although immune checkpoint inhibitors (ICIs) have provided practice-changing outcomes in treating many cancers, ICI-related gastrointestinal toxicity can limit their use. Upper gastrointestinal toxicity is not common nor as well described
Autor:
Andrew G, Kuang, Wasay, Mohajir, Kavea, Panneerselvam, Jennifer L, McQuade, Isabella C Glitz, Oliva, Muhammad Ali, Khan, Hao Chi, Zhang, Anusha S, Thomas, Yinghong, Wang
Publikováno v:
Annals of gastroenterology. 36(1)
Immune checkpoint inhibitor (ICI) therapy can be complicated by gastrointestinal adverse events (AEs). Similarly, gastrointestinal AEs have been reported with the use of serine/threonine-protein kinase B-Raf (BRAF) and mitogen-activated protein kinas
Autor:
Kavea Panneerselvam, Yinghong Wang
Publikováno v:
American Journal of Gastroenterology. 116:S1449-S1450
Autor:
John A. Thompson, Fiyinfoluwa Abraham, Jake S. Jacob, Isabella C. Glitza Oliva, Petros Grivas, Barbara E. Dutra, Anusha Shirwaikar Thomas, Yinghong Wang, Victor Garcia-Rodriguez, Hao Chi Zhang, Fangwen Zou, Weijie Ma, Kavea Panneerselvam, Mehmet Altan
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 19(12)
Background: Immune checkpoint inhibitor (ICI) therapy predisposes patients to immune-related adverse events (irAEs). Data are limited regarding the incidence, management, and outcomes of one such irAE: mucositis. In this study, we evaluated the clini
Autor:
Amishi Yogesh Shah, Pablo C. Okhuysen, Yinghong Wang, Mehmet Altan, Rajan Amin, Kavea Panneerselvam, Anusha Shirwaikar Thomas
Publikováno v:
American Journal of Gastroenterology. 116:S90-S90
Autor:
Yinghong Wang, Kavea Panneerselvam
Publikováno v:
American Journal of Gastroenterology. 116:S1040-S1040
Autor:
Weijie Ma, Yinghong Wang, Rajan Amin, Fangwen Zou, Anusha Shirwaikar Thomas, Suresh T. Chari, Shruti Khurana, Kavea Panneerselvam
Publikováno v:
Inflammatory Bowel Diseases
Autor:
David Szafron, Kavea Panneerselvam, Dongguang Wei, Rajan Amin, Pablo C. Okhuysen, Hao Chi Zhang, Shruti Khurana, Anusha Shirwaikar Thomas, Yinghong Wang, Dongfeng Tan
Publikováno v:
Gastroenterology. 160:S-51